Because most of the studies focusing on the quantification of tumor-infiltrating immune cells in HNSCC were retrospective and based on immunohistochemical data, the detailed phenotype of CD8+ T cells had not yet been evaluated. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.